October 5, 2017 6:12pm
Volume is weak as momentum flips to the downside
Pre-open indications: 1 hit
Out and about: the good, the bad, the ugly and the surprise
- The good, Mesoblast (MESO +$0.43 or +7.14%) and Regenxbio (RGNX (+$1.15 or +3.59%)
- The bad, the ugly and my anticipated losers: Capricor (CAPR -9.94% or -$0.31), Biostage (BSTG -$0.0815 or -25%), Vericel (VCEL -$0.68 or -11.3%) and Applied Genetic Technologies (AGTC -$0.10 at -2.44%)
- Surprise - Athersys (ATHX +$0.31 or +14.5%)
The interpretation of the truth of “our” universe is reported - here!
I answer one question, in which company should investors commit and keep their money. In the grip of rotating cycles and disparaging trends, what is the price of sector knowledge – a subscription!
Thursday’s results have implications to Friday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!
Henry’omics:
From the pre-open’s newsletter “what news are we waiting to hear; in this timeframe, that the probability of risks are acceptable, migratable, categorizable or even quantifiable. One indicator is how many times has a company “jumped” through the capital market window or the number of times they have raised money without significant clinical data?”
As I had stated, “How do investors avoid or minimize these impacts; many times it’s exiting after multiple “misses” of clinical data or downright failure or not investing in the first place!
But, if you are stuck … one indicator is how many times has a company “jumped” through the capital market window or the number of times they have raised money without significant clinical data?”
WE need to be … more particular of where we keep our investment dollars!
The advance/decline line scenario of 43 SCGT & RT covered companies:
· The first hour was negative with an A/DL of 18/21 and 4 flats;
· 10:30 am was negative with an A/DL of 14/27 and 3 flats;
· The mid-day was barely negative with an ADL of 20/21 and 2 flats;
· The close was again barely negative with an A/DL of 20/21 and 2 flats;
Pre-open indications: 1 hit
· Cesca Therapeutics (KOOL) closed down -$0.26 – hit;
Out and about:
The good, the bad, the ugly and the surprise – as stated above
Some of MY working trend lines or indications:
… The greatest volume to the downside: BSTG, VCEL, CAPR, SGMO and JUNO
… Upside volume was weighted to: IMUC, CYTX, ATHX, MDXG and XON
… Biggest $ downside: BLUE (-$3.40), VCEL (-$0.68), SGMO (-$0.35), ADRO (-$0.35) and CAPR (-$0.31)
… Largest $ upside: RGNX (+$1.15), XON (+$0.57), MESO (+$0.43), QURE (+0.36) and ATHX (+$0.31)
… Flat: PSTI and KITE
Shaking the tree:
CAPR closed down -$0.31 after Wednesday’s -$0.16 after Tuesday’s +$0.01 after Monday’s +$0.42 post Friday’s +$0.80 – CAPR can’t keep fooling investors for long with their brand of hype…I still think the HYPE is overplayed but, the numbers speak for themselves. As I had stated, “Take the upside, and then be cautious” …
VCEL was down -$0.68 after Wednesday’s +$0.025 after Tuesday’s +$0.05 post Monday’s -$0.15 after Friday’s +$0.40 after last Thursday’s +$0.10 – an Icarus flight and should have financed in an overnight … short sighted management
As HSGX closed up again +$0.08 post Wednesday’s +$0.02 after Tuesday’s +$0.05 after Monday’s flat again at $1.98
While AXGN was up +$0.05 after closing flat at $18.60 after Tuesday’s -$0.50 following Monday’s -$0.25 after Friday’s +0.35 while MDXG was up +$0.05 post yesterday’s +$0.72 after Tuesday’s down -$1.03 after Monday’s +$0.91 … the merry-go-round turns and burns;
AGTC was down again -$0.10 post yesterday’s -$0.05 after Tuesday’s +$0.05 post Monday’s +$0.15 … as I stated the upside won’t last? I haven’t seen or heard of ANY officer buys … AGTC can’t escape the downside trap …
BSTG was down again – big time -$0.0756 or -24.99% with 10.35 M shares after it traded after the gain – if one can’t say ANYTHING positive about this company – why say it at all … BLAME management for their thoroughly depreciated predicament! So much, for their CMO and presidents’ presentation at The ARM – Mesa KUMBAIYA conference. Throw the BUM management out with the TOXIC waste!
AST was down -$0.08 after being flat at $3.45 post being down -$0.15 after Monday’s +$0.20 while mothership BTX was again down -$0.03 post yesterday’s -$0.02 after Tuesday’s +$0.05 after Monday’s -$0.05 … they both NEED cash to prop their balance sheets
Cellectis S.A. (CLLS) dumped -$0.25 after yesterday’s jumped +$0.48 after falling -$0.34 post Monday’s pop of +$0.53, as I had stated … watch the merry-go-round but, don’t wait for the music to stop;
Immuno-oncologists - JUNO was down again another -$0.19 post yesterday’s -$0.19 after Tuesday’s -$0.64 after Monday’s +$0.88; KITE was flat again at $179.79 while BLCM was up +0.04 post yesterday’s +$0.11 after being down -$0.52 post Monday’s +$0.26 as VSTM slipped again -$0.04 post yesterday’s -$0.03 after being +$0.07 after Monday’s +$0.08;
ATHX surprised and was up +$0.31 after being down another -$0.04 post -$0.01 after Monday’s +$0.13 after Friday’s -$0.07 post last Thursday’s -$0.07 – got to be a reason other than sentiment as many question their cash position going forward and their clinical “manufacturing” issues as trials continue …
RGNX was up +$1.15 after being flat at $32.00 post being down -$1.50 but, is opting to back away from a deal to buy Dimension Therapeutics Inc. (DMTX). RGNX had announced plans to buy Dimension in an all-stock transaction. Any time one has a doubt – wait, RGNX usually rebounds … by walking they receive $2.85 M …
SGMO got dashed -$0.35 after yesterday’s +$0.25 post Tuesday’s +$0.55 after Monday’s +$1.20 after Friday’s +$0.65 while ONCE was down again -$0.04 after yesterday’s -$0.66 post yesterday’s -$1.19 after Monday’s +$0.21 as BLUE dived -$3.40 after jumping +$1.85 after Tuesday’s +$2.10 after Monday’s dropping of -$11.90
FATE was up +$0.03 post being down -$0.05 post Tuesday’s +$0.05 after Monday’s +$0.21;
MESO jumped +$0.43 after yesterday’s +$0.25 after dropping Tuesday’s -$0.03 following Monday’s +$0.32
CYTX was up again +$0.10 post yesterday’s +$0.02 post being +$0.01 after Monday’s flat at $0.358 – still looking at “strategic options” while another criminal, OSIR was up again +$0.01 after +$0.03 after being up +$0.06 after being down -$0.06
PSTI was flat at $1.50 after being up +$0.03 following being on the losing side of the trade -$0.06, when will it ever learn – it has to be considered trustworthy by shareholders
Daily analytics:
U.S. stock-market indexes posted solid gains and closed at all-time highs on Thursday after Congress passed a budget resolution—a step seen as setting the stage for an overhaul of the tax code.
· The S&P 500 index rose 14.33 points, or 0.6%, to 2,552.07, rising for an eighth straight session. The benchmark notched its sixth straight record close; marking its longest such streak since the eight consecutive all-time highs in 1997. The index has notched its 43rd record closes in 2017 so far. Among the best performing sectors, financials and technology gained about 1%.
· The NASDAQ advanced 50.73 points, or 0.8%, to 6,585.36.
· The Dow rose 113.75 points, or 0.5%, to 22,775.39, notching its 46th record close.
The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market; Thursday traded at 9.19, down -4.57% …
- Wednesday traded at 9.63, up +1.26% after Tuesday traded at 9.57, up +1.27 after Monday traded at 9.45, down -0.63% … after Friday traded at 9.51, down -0.42% after last Thursday traded at 9.55, down -3.24%
Welcome to another day of the sector’s roller coaster …
… The iShares Russell 2000 (IWM) indicated:
· Thursday was up +0.27%
· Wednesday -0.30%
· Tuesday +0.21%
· Monday +1.23
· Friday +20%
· Last Thursday +0.28%
A major indicator, the Russell 2000 (RUT) index of small stocks gained 4.32 points, or 0.3%, to 1,512.09, a fraction of a point below its record close set earlier this week.
… The iShares NASDAQ Biotechnology (IBB) indicated:
· Thursday was up +0.11%
· Wednesday +0.78%
· Tuesday -0.23%
· Monday +1.51%
· Friday +0.92%
· Last Thursday +$0.46%
The count - decliners versus gainers:
……. look at the differences in the spreads as decliners jump and %
· Thursday’s decliners ranged from -0.05% <ONCE -$0.04> to -24.99% <BSTG -$0.08> in 21 equities;
· Wednesday’s decliners ranged from -0.42% <JUNO -$0.19> to -8.32% <KOOL -$0.40> in 16 equities;
· Tuesday’s decliners ranged from -0.45% <ONVO -$0.01> to -8.05% <MDXG -$1.03> in 23 equities;
· Monday’s decliners ranged from -0.01% <KITE -$0.02> to -8.66% <BLUE -$11.90> in 14 equities;
· Friday’s decliners ranged from -0.08% <ONCE -$0.07> to -5.15% <OSIR -$0.25> in 14 equities;
· Last Thursday’s decliners ranged from -0.16% <RGNX -$0.05> to -3.29% <BSTG -$0.0105> in 14 equities;
Versus
… Look at the percentage’s (%) and spreads …
· Thursday’s gainers ranged from +0.22% <OSIR -$0.01> to +24.49% <CYTX +$0.10> in 20 equities;
· Wednesday’s gainers ranged from +0.42% <VCEL +$0.025> to +6.38% <CYTX +$0.023> in 22 equities;
· Tuesday’s gainers ranged from +0.31% <XON +$0.06> to +33.98% <KOOL +$1.22> in 18 equities;
· Monday’s gainers ranged from +0.24% <ONCE +$0.21> to +13.86% <CAPR +$0.42> in 26 equities;
· Friday’s gainers ranged from +0.04% <KITE +$0.08> to +35.87% <CAPR +$0.30> in 23 equities;
· Last Thursday’s gainers ranged from +0.03% <KITE +$0.05> to +3.13% <CUR +$0.04> in 24 equities;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
